Early studies on breast cancer cells demonstrated that silencing B7-H3 expression in the MCF-7 cell line led to an upregulation of vascular endothelial growth factor (VEGF) at both mRNA and protein levels, indicating that B7-H3 may inhibit tumor growth by suppressing VEGF expression (11). Here, CD276 is linked to breast cancer.